Treatment News : Standard Dosage Works for Overweight - by Tim Horn

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » September 2006

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

September 8, 2006

Standard Dosage Works for Overweight

by Tim Horn

Size doesn’t matter. This is the conclusion of a new study exploring whether people with high body mass indexes (BMI) – those who are overweight or obese – are less likely to respond favorably to HIV treatment. The data, published in the September issue of the Journal of Acquired Immune Deficiency Syndromes, refutes the hypothesis that larger-than-average HIV-positive people may need to be treated with higher doses of HIV medications to achieve durable viral load suppression and stable CD4 cell counts.

Studies have demonstrated that BMI can influence the way drugs are metabolized and distributed in the body. For example, a possible reason why women may be more likely to experience certain side effectsor have more severe side effect symptomsis because their average body weights are lower than the average body weights of the males that make up the vast majority of dose-determining clinical trials. In other words, some women may be taking higher doses of a drug than they need, based on their lower body weight.

On the other end of the spectrum are people who are overweight or obese. The U.S. Centers for Disease Control’s HIV Outpatient Study (HOPS) conducted a study to evaluate whether overweight or obese HIV-positive peoplewho, like people of lower-than-average body weight may not be adequately represented in clinical trialsare more likely to experience treatment failure, due to the possibility of too little medication in their bodies.

Using data collected in HOPS, an ongoing cohort involving thousands of HIV-positive people, Ellen Tedaldi, MD, and her colleagues analyzed the association of BMI with achieving an undetectable viral load and experiencing a CD4 count increase of more than 100 cells after three to nine month of HIV treatment.

Among 711 patients included in analysis, 43% had a BMI of more than 25, which is considered to be overweight or obese.* Higher BMI was associated with being female, being black or Hispanic, being heterosexual, and using injection drugs. Although average pre-treatment viral loads were significantly lower in obese participants, overweight or obese BMI did not significantly alter the likelihood of achieving an undetectable viral load and a CD4 cell count increase of more than 100 cells compared with lower-weight study participants.

In conclusion, Dr. Tedali’s group indicated that a substantial proportion of the patients included in the HOPS analysis were overweight or obese. However, increased BMI was not associated with decreased virologic or immunologic responses to HIV treatment. This, they suggest, argues against the likelihood of requiring higher-dose treatment to manage HIV in larger-than-average patients.

Other studies, exploring the possibility of using lower-dose therapy in HIV-positive people with below-average body weights to potentially reduce the risk of side effects, have not yet been conducted.

* To calculate your BMI, first multiply your height in inches by your height in inches (e.g., 74” X 74” = 5,476). Next divide that number into your body weight (e.g., 200 / 5476 = 0.0365). Finally multiple that number by 703 (0.0365 X 703 = 25.66). This final number is your BMI. The National Heart, Lung, and Blood Institute has an automated calculator that can be used to calculate your BMI.

While BMI is considered to be a reliable indicator of total body fat, it does have some limits. It may overestimate body fat in people who have muscular builds and may underestimate body fat in some people, including people with AIDS-related wasting, who have lost muscle mass.


[Go to top]


Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    acousticmat
    Tucson
    Arizona


    romanticseattle
    Tacoma
    Washington


    sefarady
    New York
    California


    RayOctober
    Richmond
    Virginia
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Are you a regular coffee drinker?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.